Framingham risk score is related to carotid artery intima-media thickness in both white and black young adults: the Bogalusa Heart Study☆
Received 9 October 2002; received in revised form 29 May 2003; accepted 2 June 2003.
Abstract
The Framingham risk score (FRS), developed in a white cohort aged 30–74 years, is increasingly used in the early risk identification for coronary artery disease (CAD). This study examines the relationship between FRS and carotid artery intima-media thickness (IMT), a surrogate marker of coronary atherosclerosis, in black and white individuals aged 20–37 years. Five hundred seventeen young adults (aged 20–37 years; 71% white, 39% male) enrolled in the Bogalusa Heart Study had carotid artery ultrasonography. Age, gender, systolic blood pressure, total cholesterol to HDL cholesterol ratio, cigarette smoking habit, type 2 diabetes, and left ventricular hypertrophy (LVH) were used to calculate FRS. Results indicated a significant, positive linear relationship between tertiles of FRS and IMT of the common, bulb, and internal carotid segments in blacks and whites alike. In a multivariate analysis including FRS, race, BMI, parental history of CAD, stroke, type 2 diabetes, or hypertension, logtriglycerides, loginsulin, alcohol consumption (ml/week), and regular physical activity, the FRS was independently associated with all three carotid segments. Further, the FRS as a main predictor variable explained relatively more of the variance in the IMT of the carotid bulb (9%) than in the common (5%) or internal (3%) carotid segments. These results support the use of FRS in both white and black young adults and underscore the importance of prevention and control of multiple risk factors in youth.
aTulane Center for Cardiovascular Health, Tulane School of Public Health and Tropical Medicine, 1440 Canal Street, Suite 2140, New Orleans, LA 70112, USA
bDivision of Vascular Ultrasound Research, Wake Forest University School of Medicine, Winston-Salem, NC, USA
Corresponding author. Tel.: +1-504-585-7194
☆ Supported by grants HL38844 from the National Heart, Lung and Blood Institute and AG16592 from the National Institute on Aging.